Seminoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Seminoma}} ==References== {{reflist|2}} [...")
 
 
(27 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{Seminoma}}
{{Seminoma}}
{{CMG}}{{AE}}{{S.G.}}
==Overview==
The [[incidence]] of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States. [[Testicular]] [[cancer]] is the most common type of cancer in young males. [[Germ cell tumors]] are about 98% of [[testicular]] [[cancer]]. About 55% of [[germ cell tumors]] are seminomas.The prevalence of [[testicular]] [[cancer]] is estimated to be  9,310 new cases in 2018. Seminoma commonly affects individuals young adults 15 and 35  years of age. Seminoma is usually first diagnosed among 34 years (median, 39.5 years). The majority of seminoma cases are reported in Europe, Scandinavia and North America.
==Epidemiology==
===Incidence===
*The [[incidence]] of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States.<ref name="urlTesticular Cancer - Cancer Stat Facts">{{cite web |url=https://seer.cancer.gov/statfacts/html/testis.html |title=Testicular Cancer - Cancer Stat Facts |format= |work= |accessdate=}}</ref>
===Prevalence===
*[[Testicular]] [[cancer]] is the most common type of cancer in young males.<ref name="pmid242041712">{{cite journal |vauthors=Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M |title=Global incidence and outcome of testicular cancer |journal=Clin Epidemiol |volume=5 |issue= |pages=417–27 |date=October 2013 |pmid=24204171 |pmc=3804606 |doi=10.2147/CLEP.S34430 |url=https://dx.doi.org/10.2147/CLEP.S34430}}</ref><ref name="pmid30620402">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2019 |journal=CA Cancer J Clin |volume=69 |issue=1 |pages=7–34 |date=January 2019 |pmid=30620402 |doi=10.3322/caac.21551 |url=}}</ref>
*[[Germ cell tumors]] are about 98% of [[testicular]] [[cancer]].<ref name="pmid20447912">{{cite journal |vauthors=Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA |title=International trends in the incidence of testicular cancer, 1973-2002 |journal=Cancer Epidemiol. Biomarkers Prev. |volume=19 |issue=5 |pages=1151–9 |date=May 2010 |pmid=20447912 |pmc=2867073 |doi=10.1158/1055-9965.EPI-10-0031 |url=}}</ref>
**About 55% of [[germ cell tumors]] are seminomas
*The prevalence of [[testicular]] [[cancer]] is estimated to be  9,310 new cases in 2018.<ref name="urlTesticular Cancer - Cancer Stat Facts">{{cite web |url=https://seer.cancer.gov/statfacts/html/testis.html |title=Testicular Cancer - Cancer Stat Facts |format= |work= |accessdate=}}</ref>
===Age===
*Seminoma commonly affects individuals young adults 15 and 35  years of age.<ref name="CheTamboli2002">{{cite journal|last1=Che|first1=Mingxin|last2=Tamboli|first2=Pheroze|last3=Ro|first3=Jae Y.|last4=Park|first4=Dong Soo|last5=Ro|first5=Jung Sil|last6=Amato|first6=Robert J.|last7=Ayala|first7=Alberto G.|title=Bilateral testicular germ cell tumors|journal=Cancer|volume=95|issue=6|year=2002|pages=1228–1233|issn=0008-543X|doi=10.1002/cncr.10804}}</ref>
*Seminoma is usually first diagnosed among 34 years (median, 39.5 years).<ref name="pmid27184033">{{cite journal |vauthors=Di Gregorio M, Nollevaux MC, Lorge F, D'Hondt L |title=Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report |journal=World J Surg Oncol |volume=14 |issue= |pages=147 |date=May 2016 |pmid=27184033 |pmc=4867539 |doi=10.1186/s12957-016-0902-9 |url=}}</ref>
===Race===
*Seminoma usually affects individuals of the white race. Black individuals are less likely to develop seminoma (ratio of 5 : 1).<ref name="pmid19903067">{{cite journal |vauthors=McGlynn KA, Cook MB |title=Etiologic factors in testicular germ-cell tumors |journal=Future Oncol |volume=5 |issue=9 |pages=1389–402 |date=November 2009 |pmid=19903067 |pmc=3000220 |doi=10.2217/fon.09.116 |url=}}</ref>
===Gender===
*Seminoma affects exclusively in men.
===Region===
*The majority of seminoma cases are reported in Europe, Scandinavia and North America.<ref name="pmid24204171">{{cite journal |vauthors=Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M |title=Global incidence and outcome of testicular cancer |journal=Clin Epidemiol |volume=5 |issue= |pages=417–27 |date=October 2013 |pmid=24204171 |pmc=3804606 |doi=10.2147/CLEP.S34430 |url=}}</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Oncology]]
 
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Needs content]]
[[Category:Oncology]]
 
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Urology]]

Latest revision as of 13:33, 15 May 2019

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma epidemiology and demographics

CDC on Seminoma epidemiology and demographics

Seminoma epidemiology and demographics in the news

Blogs on Seminoma epidemiology and demographics

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

The incidence of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States. Testicular cancer is the most common type of cancer in young males. Germ cell tumors are about 98% of testicular cancer. About 55% of germ cell tumors are seminomas.The prevalence of testicular cancer is estimated to be 9,310 new cases in 2018. Seminoma commonly affects individuals young adults 15 and 35 years of age. Seminoma is usually first diagnosed among 34 years (median, 39.5 years). The majority of seminoma cases are reported in Europe, Scandinavia and North America.

Epidemiology

Incidence

  • The incidence of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States.[1]

Prevalence

Age

  • Seminoma commonly affects individuals young adults 15 and 35 years of age.[5]
  • Seminoma is usually first diagnosed among 34 years (median, 39.5 years).[6]

Race

  • Seminoma usually affects individuals of the white race. Black individuals are less likely to develop seminoma (ratio of 5 : 1).[7]

Gender

  • Seminoma affects exclusively in men.

Region

  • The majority of seminoma cases are reported in Europe, Scandinavia and North America.[8]

References

  1. ↑ 1.0 1.1 "Testicular Cancer - Cancer Stat Facts".
  2. ↑ Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M (October 2013). "Global incidence and outcome of testicular cancer". Clin Epidemiol. 5: 417–27. doi:10.2147/CLEP.S34430. PMC 3804606. PMID 24204171.
  3. ↑ Siegel RL, Miller KD, Jemal A (January 2019). "Cancer statistics, 2019". CA Cancer J Clin. 69 (1): 7–34. doi:10.3322/caac.21551. PMID 30620402.
  4. ↑ Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (May 2010). "International trends in the incidence of testicular cancer, 1973-2002". Cancer Epidemiol. Biomarkers Prev. 19 (5): 1151–9. doi:10.1158/1055-9965.EPI-10-0031. PMC 2867073. PMID 20447912.
  5. ↑ Che, Mingxin; Tamboli, Pheroze; Ro, Jae Y.; Park, Dong Soo; Ro, Jung Sil; Amato, Robert J.; Ayala, Alberto G. (2002). "Bilateral testicular germ cell tumors". Cancer. 95 (6): 1228–1233. doi:10.1002/cncr.10804. ISSN 0008-543X.
  6. ↑ Di Gregorio M, Nollevaux MC, Lorge F, D'Hondt L (May 2016). "Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report". World J Surg Oncol. 14: 147. doi:10.1186/s12957-016-0902-9. PMC 4867539. PMID 27184033.
  7. ↑ McGlynn KA, Cook MB (November 2009). "Etiologic factors in testicular germ-cell tumors". Future Oncol. 5 (9): 1389–402. doi:10.2217/fon.09.116. PMC 3000220. PMID 19903067.
  8. ↑ Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M (October 2013). "Global incidence and outcome of testicular cancer". Clin Epidemiol. 5: 417–27. doi:10.2147/CLEP.S34430. PMC 3804606. PMID 24204171.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Seminoma_epidemiology_and_demographics&oldid=1568210"